Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Alabama guideAlabama Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Alabama
  4. ›Closed bids
  5. ›BCL26*364031-Geenius HIV 1/2 controls ,Viroclear 1x5ml-STD

State of Alabama·Alabama

BCL26*364031-Geenius HIV 1/2 controls ,Viroclear 1x5ml-STD

Closes 8/3/2026$20k – $25kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This solicitation is a Quick‑Quote (RFQ) for the provision of diagnostic control materials for HIV‑1/2 testing (Geenius HIV 1/2 controls) and a Viroclear 1 × 5 ml standard. The State of Alabama seeks a vendor able to supply these specific laboratory reagents on an as‑needed basis, adhering to the standard Quick‑Quote terms and conditions (including electronic submission via Alabama Buys, E‑Verify compliance, and a contract ceiling of $25,000). • Supplies: Geenius HIV 1/2 control kits and Viroclear 1 × 5 ml standards. • Delivery: Must meet the State’s electronic ordering and invoicing processes; timely fulfillment before the contract deadline (Aug 3 2026). • Compliance: Vendor must be registered in Alabama Buys, not debarred, and able to provide E‑Verify documentation within 5 days if employing Alabama workers.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Key dates

Opened
7/27/2026
Closes
8/3/2026

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
339112
Solicitation №
SRC0000034804

Budget estimate

$20,000 – $25,000

The boiler‑plate caps Quick‑Quote contracts at $25,000 total (including any renewals). Assuming the State will use the full allowance for these specialized controls, the expected award will likely fall between $20,000 and $25,000, reflecting the cost of the control kits, shipping, and any associated fees.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 63%

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

61% match

HIV/AIDS Clinical Trials Network Statistical and Data Management Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

61% match

HIV/AIDS Clinical Trials Network Leadership and Operations Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

61% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

61% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. Centers for Disease Control - NCHHSTP·United States of America

61% match

Controlling and Preventing STIs in US Health Departments (CAP-STIs)

Closes 2/9/2027Opened 5/11/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

61% match

Department of Defense HIV/AIDS Prevention Program

Closes 9/18/2027Opened 9/19/2022

U.S. National Institutes of Health·United States of America

61% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026

Health, NYS Dept. of·New York

61% match

Congenital Syphilis Prevention

Rolling / TBD closeOpened 7/15/2026

Department of Public Health·South Carolina

60% match

Sole Source Procurement for INSTI HIV‑1/HIV‑2 Antibody Test Kits and Controls

Rolling / TBD closeOpened 9/8/2026

U.S. National Institutes of Health·United States of America

60% match

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

The City of Columbus·Ohio

60% match

RFQ033803 - Safe Syringe and Harm Reduction Services FY27

Closes 10/27/2026Opened 10/7/2026

U.S. National Institutes of Health·United States of America

60% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. Centers for Disease Control - NCHHSTP·United States of America

60% match

Direct-to-Consumer Distribution of HIV and other STI Self-Tests

Closes 9/29/2027Opened 7/27/2026

U.S. National Institutes of Health·United States of America

60% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

Iowa Department of Health and Human Services·Iowa

60% match

HIV Client Services

Closes 12/8/2026Opened 9/27/2026

U.S. National Institutes of Health·United States of America

60% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

60% match

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)

Closes 10/17/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

60% match

Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks

Closes 10/21/2026Opened 3/16/2026

U.S. National Institutes of Health·United States of America

60% match

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Closes 5/24/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

59% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center

Closes 10/31/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

59% match

HIV/AIDS Clinical Trials Network Clinical Trials Units

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

59% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

59% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

59% match

Translational Centers Using Microphysiologic Systems for Infectious Diseases

Closes 1/28/2027Opened 6/24/2026